BCL2 and ovarian carcinoma: Zhu et al. have reported that ALKBH5 enhanced the stability of BCL-2 mRNA in epithelial ovarian cancer, thus enhancing the binding of Bcl-2 and Beclin1, which eventually prohibited autophagy and remarkably increased the proliferation of epithelial ovarian cancer cells [92].